Oral fingolimod (gilenya) for multiple sclerosis

Med Lett Drugs Ther. 2010 Dec 29;52(1353-1354):98-9.
No abstract available

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Animals
  • Fingolimod Hydrochloride
  • Headache / chemically induced
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / pharmacokinetics
  • Multiple Sclerosis / drug therapy*
  • Propylene Glycols / administration & dosage*
  • Propylene Glycols / adverse effects
  • Propylene Glycols / pharmacokinetics
  • Randomized Controlled Trials as Topic / methods
  • Sphingosine / administration & dosage
  • Sphingosine / adverse effects
  • Sphingosine / analogs & derivatives*
  • Sphingosine / pharmacokinetics

Substances

  • Immunosuppressive Agents
  • Propylene Glycols
  • Fingolimod Hydrochloride
  • Sphingosine